Proteomic identification of salivary biomarkers of type-2 diabetes

Journal of Proteome Research

Volumn 8, Issue 1, 2009, Pages 239-245

  Rao, Paturi V ^a   Reddy, Ashok P ^b   Lu, Xinfang ^b   Dasari, Surendra ^b   Krishnaprasad, Adiraju ^a   Biggs, Evan ^b   Roberts, Charles T ^b   Nagalla, Srinivasa R ^b  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b DiabetOmics LLC   (United States)

Author keywords

Diabetes; Diagnosis; Human; Preclinical; Prediabetes; Proteome; Saliva

Indexed keywords

ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; CYSTATIN C; PREALBUMIN; SALIVA PROTEIN; SOMATOMEDIN; PROTEOME;

ADULT; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BIOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; EXTRACELLULAR MATRIX; FUNCTIONAL PROTEOMICS; HUMAN; IMMUNE RESPONSE; IMMUNODETECTION; IMMUNOREGULATION; IMPAIRED GLUCOSE TOLERANCE; LIQUID CHROMATOGRAPHY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; INFLAMMATION; MASS SCREENING; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PROTEOMICS; SALIVA;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; MASS SCREENING; MASS SPECTROMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEOME; PROTEOMICS; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 60849127257     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8003776     Document Type: Article

References (35)

1. Harris, M. I.; Klein, R.; Welborn, T. A.; Knuiman, M. W. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992, 15 (7), 815-9.
2. Rao, P. V.; Lu, X.; Standley, M.; Pattee, P.; Neelima, G.; Girisesh, G.; Dakshinamurthy, K. V.; Roberts, C. T., Jr.; Nagalla, S. R. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30 (3), 629-37.
3. Denny, P.; Hagen, F. K.; Hardt, M.; Liao, L.; Yan, W.; Arellanno, M.; Bassilian, S.; Bedi, G. S.; Boontheung, P.; Cociorva, D.; Delahunty, C. M.; Denny, T.; Dunsmore, J.; Faull, K. F.; Gilligan, J.; Gonzalez-Begne, M.; Halgand, F.; Hall, S. C.; Han, X.; Henson, B.; Hewel, J.; Hu, S.; Jeffrey, S.; Jiang, J.; Loo, J. A.; Ogorzalek Loo, R. R.; Malamud, D.; Melvin, J. E.; Miroshnychenko, O.; Navazesh, M.; Niles, R.; Park, S. K.; Prakobphol, A.; Ramachandran, P.; Richert, M.; Robinson, S.; Sondej, M.; Souda, P.; Sullivan, M. A.; Takashima, J.; Than, S.; Wang, J.; Whitelegge, J. P.; Witkowska, H. E.; Wolinsky, L.; Xie, Y.; Xu, T.; Yu, W.; Ytterberg, J.; Wong, D. T.; Yates, J. R.; Fisher, S. J. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J. Proteome Res. 2008, 7 (5), 1994-2006.
4. Hu, S.; Loo, J. A.; Wong, D. T. Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics 2007, 4 (4), 531-8.
5. Bernardi, M. J.; Reis, A.; Loguercio, A. D.; Kehrig, R.; Leite, M. F.; Nicolau, J. Study of the buffering capacity, pH and salivary flow rate in type 2 well-controlled and poorly controlled diabetic patients. Oral Health Prev. Dent. 2007, 5 (1), 73-8.
6. Collin, H. L.; Sorsa, T.; Meurman, J. H.; Niskanen, L.; Salo, T.; Ronka, H.; Konttinen, Y. T.; Koivisto, A. M.; Uusitupa, M. Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J. Periodontal. Res. 2000, 35 (5), 259-65.
7. Oxford, G. E.; Tayari, L.; Barfoot, M. D.; Peck, A. B.; Tanaka, Y.; Humphreys-Beher, M. G. Salivary EGF levels reduced in diabetic patients. J. Diabetes Complications 2000, 14 (3), 140-5.
8. Nagalla, S. R.; Canick, J. A.; Jacob, T.; Schneider, K. A.; Reddy, A. P.; Thomas, A.; Dasari, S.; Lu, X.; Lapidus, J. A.; Lambert-Messerlian, G. M.; Gravett, M. G.; Roberts, C. T., Jr.; Luthy, D.; Malone, F. D.; D'Alton, M. E. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. J. Proteome Res. 2007, 6 (4), 1245-57.
9. Craig, R.; Beavis, R. C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20 (9), 1466-7.
10. Fenyo, D.; Beavis, R. C. A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes. Anal. Chem. 2003, 75 (4), 768-74.
11. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75 (17), 4646-58.
12. Old, W. M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K. G.; Mendoza, A.; Sevinsky, J. R.; Resing, K. A.; Ann, N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 2005, 4 (10), 1487-502.
13. Liu, H.; Sadygov, R. G.; Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun pro-teomics. Anal. Chem. 2004, 76 (14), 4193-201.
14. Zybailov, B.; Coleman, M. K.; Florens, L.; Washburn, M. P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 2005, 77 (19), 6218-24.
15. Zybailov, B.; Mosley, A. L.; Sardiu, M. E.; Coleman, M. K.; Florens, L.; Washburn, M. P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 2006, 5 (9), 2339-47.
16. Gravett, M. G.; Thomas, A.; Schneider, K. A.; Reddy, A. P.; Dasari, S.; Jacob, T.; Lu, X.; Rodland, M.; Pereira, L.; Sadowsky, D. W.; Roberts, C. T., Jr.; Novy, M. J.; Nagalla, S. R. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J. Proteome Res. 2007, 6 (1), 89-96.
17. Pereira, L.; Reddy, A. P.; Jacob, T.; Thomas, A.; Schneider, K. A.; Dasari, S.; Lapidus, J. A.; Lu, X.; Rodland, M.; Roberts, C. T., Jr.; Graven, M. G.; Nagalla, S. R. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J. Proteome Res. 2007, 6 (4), 1269-76.
18. Pang, J. X.; Ginanni, N.; Dongre, A. R.; Hefta, S. A.; Opitek, G. J. Biomarker discovery in urine by proteomics. J. Proteome Res. 2002, 1 (2), 161-9.
19. Fernandez-Real, J. M.; Pickup, J. C. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 2008, 19(1), 10-6.
20. Pickup, J. C; Crook, M. A. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998, 41 (10), 1241-8.
21. Larsson, A.; Helmersson, J.; Hansson, L. O.; Basu, S. Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men. Int. J. Cardiol. 2008, 125 (2), 263-4.
22. Piwowar, A.; Knapik-Kordecka, M.; Warwas, M. Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin. Chem. Lab. Med. 2000, 38 (12), 1257-61.
23. Hong, C. Y.; Chia, K. S. Markers of diabetic nephropathy. J. Diabetes Complications 1998, 12 (1), 43-60.
24. Qiang, H.; Zhou, Z. X.; Ma, A. Q.; Cheng, H.; Zhou, P. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]. Nanfang Yike Daxue Xuebao 2007, 27 (6), 831-3.
25. Sundsten, T.; Ostenson, C. G.; Bergsten, P. Serum protein patterns in newly diagnosed type 2 diabetes mellitus-influence of diabetic environment and family history of diabetes. Diabetes Metab. Res. Rev. 2008, 24 (2), 148-54.
26. Zhang, B.; Lu, Y.; Campbell-Thompson, M.; Spencer, T.; Wasserfall, C.; Atkinson, M.; Song, S. Alphal-antitrypsin protects beta-cells from apoptosis. Diabetes 2007, 56 (5), 1316-23.
27. Graham, T. E.; Yang, Q.; Bluher, M.; Hammarstedt, A.; Ciaraldi, T. P.; Henry, R. R.; Wason, C. J.; Oberbach, A.; Jansson, P. A.; Smith, U.; Kahn, B. B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 2006, 354 (24), 2552-63.
28. Cabre, A.; Lazaro, I.; Girona, J.; Manzanares, J.; Marimon, F.; Plana, N.; Heras, M.; Masana, L. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J. Intern. Med. 2007, 262 (4), 496-503.
29. Lisowska-Myjak, B.; Pachecka, J.; Kaczynska, B.; Miszkurka, G.; Kadziela, K. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol. 2006, 43 (4), 88-92.
30. Annapoorani, P.; Dhandapany, P. S.; Sadayappan, S.; Ramasamy, S.; Rathinavel, A.; Selvam, G. S. Cardiac isoform of alpha-2 macroglobulin-a new biomarker for myocardial infarcted diabetic patients. Atherosclerosis 2006, 186(1), 173-6.
31. Aurer, A.; Jorgic-Srdjak, K.; Plancak, D.; Stavljenic-Rukavina, A.; Aurer-Kozelj, J. Proinflammatory factors in saliva as possible markers for periodontal disease. Coll. Antropol. 2005, 29 (2), 435-9.
32. Gambhir, K. K.; Ornasir, J.; Headings, V.; Bonar, A. Decreased total carbonic anhydrase esterase activity and decreased levels of carbonic anhydrase 1 isozyme in erythrocytes of type II diabetic patients. Biochem. Genet. 2007, 45 (5-6), 431-9.
33. Hogue, J. C.; Lamarche, B.; Tremblay, A. J.; Bergeron, J.; Gagne, C.; Couture, P. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J. Lipid Res. 2007, 48 (6), 1336-42.
34. Hegele, R. A. Phenomics, lamin A/C, and metabolic disease. J. Clin. Endocrinol. Metab. 2007, 92 (12), 4566-8.
35. Gaede, P.; Lund-Andersen, H.; Parving, H. H.; Pedersen, O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 2008, 358 (6), 580-91.